Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Hara-Cleaver

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neuroepidemiology|June 17, 2010
Validation of a self-report comorbidity questionnaire for multiple sclerosisMyles Horton, Richard A Rudick, Claire Hara-Cleaver, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 12, 2024
Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFFIRM trialKunio Nakamura, Zhaonan Sun, Claire Hara-Cleaver, et al.
Journal of the Neurological Sciences|October 9, 2012
Early tolerability and safety of fingolimod in clinical practiceDaniel Ontaneda, Claire Hara-Cleaver, Richard A Rudick, et al.
JAMA Neurology|April 20, 2013
Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinicEdru Erbayat Altay, Elizabeth Fisher, Stephen E Jones, et al.
The International Journal of Neuroscience|October 2, 2014
Experience with fingolimod in clinical practiceCarrie M Hersh, Claire Hara-Cleaver, Richard A Rudick, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-upCarrie M Hersh, Thomas E Love, Samuel Cohn, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 12, 2017
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-upCarrie M Hersh, Thomas E Love, Anasua Bandyopadhyay, et al.
Neurology. Clinical Practice|July 10, 2020
Technology-enabled assessments to enhance multiple sclerosis clinical care and researchGabrielle Macaron, Brandon P Moss, Hong Li, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neuroepidemiology|June 17, 2010
Validation of a self-report comorbidity questionnaire for multiple sclerosisMyles Horton, Richard A Rudick, Claire Hara-Cleaver, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 12, 2024
Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFFIRM trialKunio Nakamura, Zhaonan Sun, Claire Hara-Cleaver, et al.
Journal of the Neurological Sciences|October 9, 2012
Early tolerability and safety of fingolimod in clinical practiceDaniel Ontaneda, Claire Hara-Cleaver, Richard A Rudick, et al.
JAMA Neurology|April 20, 2013
Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinicEdru Erbayat Altay, Elizabeth Fisher, Stephen E Jones, et al.
The International Journal of Neuroscience|October 2, 2014
Experience with fingolimod in clinical practiceCarrie M Hersh, Claire Hara-Cleaver, Richard A Rudick, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-upCarrie M Hersh, Thomas E Love, Samuel Cohn, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 12, 2017
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-upCarrie M Hersh, Thomas E Love, Anasua Bandyopadhyay, et al.
Neurology. Clinical Practice|July 10, 2020
Technology-enabled assessments to enhance multiple sclerosis clinical care and researchGabrielle Macaron, Brandon P Moss, Hong Li, et al.
Pageof 1